Sign in

CIK 0000842023 · Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
operating
EIN
411427402
Phone
612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-08-18 Bazan J. Fernando Chief Technical Officer Grant or award · Stock Option (Right to Buy) +14,476 14,476
2016-08-18 Bazan J. Fernando Chief Technical Officer Grant or award · Stock Option (Right to Buy) +10,857 10,857
2016-08-18 Bazan J. Fernando Chief Technical Officer Grant or award · Restricted Stock Units +1,759 1,759
2016-08-18 Gavin Robert M. Senior V.P. Protein Platforms Grant or award · Stock Option (Right to Buy) +17,371 17,371
2016-08-18 Gavin Robert M. Senior V.P. Protein Platforms Grant or award · Stock Option (Right to Buy) +13,028 13,028
2016-08-18 Gavin Robert M. Senior V.P. Protein Platforms Grant or award · Restricted Stock Units +2,111 2,111
2016-08-18 Gould Kevin S SVP Clinical Controls Grant or award · Stock Options (Right to Buy) +17,371 17,371
2016-08-18 Gould Kevin S SVP Clinical Controls Grant or award · Stock Options (Right to Buy) +13,028 13,028
2016-08-18 Gould Kevin S SVP Clinical Controls Grant or award · Restricted Stock Units +2,111 2,111
2016-08-18 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Option (Right to Buy) +14,476 14,476
2016-08-18 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Option (Right to Buy) +10,857 10,857
2016-08-18 Furlow Brenda S. SVP - General Counsel Grant or award · Restricted Stock Units +1,759 1,759
2016-08-18 Eansor Norman David SVP - Biotech Grant or award · Stock Option (Right to Buy) +18,819 18,819
2016-08-18 Eansor Norman David SVP - Biotech Grant or award · Stock Option (Right to Buy) +14,114 14,114
2016-08-18 Eansor Norman David SVP - Biotech Grant or award · Restricted Stock Units +2,287 2,287
2016-08-18 Hippel James Chief Financial Officer Grant or award · Stock Option (Right to Buy) +40,533 40,533
2016-08-18 Hippel James Chief Financial Officer Grant or award · Stock Option (Right to Buy) +30,400 30,400
2016-08-18 Hippel James Chief Financial Officer Grant or award · Restricted Stock Unit +4,925 4,925
2016-08-18 Kummeth Charles R. Chief Executive Officer Grant or award +16,653 61,030
2016-08-18 Kummeth Charles R. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +102,779 102,779

Page 62 of 64 · 1,274 trades